Could lithium ease autism symptoms? small study hints at hope for rare genetic form
NCT ID NCT04623398
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 19 times
Summary
This study tested whether lithium, a drug used for mood disorders, can improve social communication in children with autism and Phelan-McDermid syndrome (a rare genetic condition). Twenty-two children took lithium for 12 weeks. Researchers measured changes in social responsiveness. The goal was to see if lithium could ease core autism symptoms, offering a new treatment path for this specific group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Robert Debré
Paris, 75019, France
Conditions
Explore the condition pages connected to this study.